Transaction in Own Shares

For immediate release

                                                               13 February 2009

                  FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC                  

                                (the "Company")                                

                    MARKET PURCHASE OF COMPANY'S OWN SHARES                    

Notification is given, pursuant to the authority granted at the Annual General
Meeting of the Company held on 23 July 2008 to make market purchases of the
Company's own shares up to an aggregate maximum of 6,656,521 that a market
total of 287,000 Ordinary shares of 25p each in the capital of the Company were
purchased today by the Company at a price of 578.16p per share. Such shares
will be held as treasury shares.

Following this transaction and in conformity with the provisions of the
Transparency Directive, the Company hereby notifies the market that: the total
number of Ordinary shares held by the Company in treasury following the
purchase is 2,048,750; and the total number of Ordinary shares that the Company
has in issue, less the total number of Ordinary shares held by the Company in
treasury following such purchase, and therefore, the total number of voting
rights in the Company is 42,370,731.

The figure of 42,370,731 may be used by shareholders as the denominator for the
calculation by which they may determine if they are required to notify their
interest in, or change to their interest in, the Company under the FSA's
Disclosure and Transparency Rules.

For and on behalf of

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Mark Pope

Frostrow Capital LLP

Tel: [phone]